Safety and Efficacy of Pulsed Inhaled Nitric Oxide in Subjects With Pulmonary Fibrosis 2018-06-15T21:11:13+00:00

Clinical Trials

June 11, 2018

A Randomized, Double-Blind, Placebo-Controlled Clinical Study to Assess the Safety and Efficacy of Pulsed, Inhaled Nitric Oxide (INO) in Subjects with Pulmonary Hypertension Associated with Pulmonary Fibrosis on Long Term Oxygen Therapy (Part 1 and Part 2)

  • Study Sponsor: Bellerophon Therapeutics
  • Institution: Bellerophon Therapeutics
  • Start Date: Friday, Dec. 22, 2017
  • End Date: Friday, Aug. 31, 2018
  • Design: Placebo-controlled
  • Age range (years): from 18 to 80
  • Type of PH
    • PH with lung involvement (Group 3)
  • Study Duration for individual patient: 9 weeks
  • Contact: http://patients.bellerophon.com/
  • Listing on clinicaltrials.gov